Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;53(2):204-10.
doi: 10.1007/s12031-014-0286-7. Epub 2014 Mar 28.

Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene

Affiliations

Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene

Bernadett Balla et al. J Mol Neurosci. 2014 Jun.

Abstract

Neurofibromatosis type 1 (NF1) gene exhibits one of the highest spontaneous mutation rates in the human genome. Identification of the NF1 mutation is challenging because the NF1 gene is very large and complex, lacking mutational "hot spots." There is no clustering of mutations, there are several pseudogenes, and a wide spectrum of different types of mutation has been recognized. To date, NF1 mutations or deleted regions have been detected with a number of techniques. With the appearance of next-generation sequencing (NGS) machines, molecular biology is in a new revolutionary phase. Our aim was to work out a method to use the high-throughput NGS machine, Ion Torrent PGM, in diagnostic settings for neurofibromatosis type 1. In our examination, we could reveal 21 distinct variations in NF1 gene in seven patients. This is an absolutely new method for exploring the genetic background of neurofibromatosis type 1 exhibiting the extremely high throughput of NGS in a diagnostic setting.

PubMed Disclaimer

References

    1. Ann Hum Genet. 2013 Sep;77(5):364-79 - PubMed
    1. J Clin Invest. 2013 Jan;123(1):340-7 - PubMed
    1. Nat Biotechnol. 2003 Feb;21(2):194-7 - PubMed
    1. Curr Opin Neurol. 2007 Apr;20(2):135-41 - PubMed
    1. Pediatr Neurol. 2013 Jun;48(6):447-53 - PubMed

Substances

LinkOut - more resources